Viral DNA in horses infected with equine infectious anemia virus. by N R Rice et al.
Vol. 63, No. 12JOURNAL OF VIROLOGY, Dec. 1989, p. 5194-5200
0022-538X/89/125194-07$02.00/0
Copyright © 1989, American Society for Microbiology
Viral DNA in Horses Infected with Equine Infectious Anemia Virus
NANCY R. RICE,'* ANNE-SOPHIE LEQUARRE,1 JAMES W. CASEY,2 SHARON LAHN,1
ROBERT M. STEPHENS,1 AND JOHN EDWARDS3
BRI-Basic Research Program, National Cancer Institute-Frederick Cancer Research Facility, Frederick, Maryland
217011; Department of Microbiology, New York State College of Veterinary Medicine, Cornell University,
Ithaca, New York 148532; and Department of Veterinary Pathology, College of Veterinary Medicine,
Texas A & M University, College Station, Texas 778433
Received 1 May 1989/Accepted 9 August 1989
The amount and distribution of viral DNA were established in a horse acutely infected with the Wyoming
strain of equine infectious anemia virus (EIAV). The highest concentrations of viral DNA were found in the
liver, lymph nodes, bone marrow, and spleen. The kidney, choroid plexus, and peripheral blood leukocytes
also contained viral DNA, but at a lower level. It is estimated that at day 16 postinoculation, almost all of the
viral DNA was located in the tissues, with the liver alone containing about 90 times more EIAV DNA than the
peripheral blood leukocytes did. Assuming a monocyte-macrophage target, each infected cell contained
multiple copies of viral DNA (between 6 and 60 copies in liver Kupffer cells). At day 16 postinoculation, most
of the EIAV DNA was not integrated into host DNA, but existed in both linear and circular unintegrated forms.
In contrast to acute infection, viral DNA was not detectable in tissues from asymptomatic horses with
circulating antibody to EIAV.
Equine infectious anemia virus (EIAV) is a lentivirus that
is distantly related to the human immunodeficiency virus
(HIV), the causative agent of acquired immunodeficiency
syndrome (4, 9, 13, 24, 25). Like HIV, EIAV establishes a
persistent infection in the host (see references 3 and 22 for
reviews), with blood cells remaining infectious after disease-
free intervals of many years (6, 11). The principal target and
reservoir of EIAV is a leukocyte, probably the macrophage
(14, 20, 21). The disease course caused by EIAV is quite
variable. Depending on the virus strain and the host, an
infected animal may (i) die following a brief acute illness; (ii)
recover from an initial clinical episode and have a variable
number of additional recrudescences over time, followed by
death or recovery; or (iii) remain clinically normal, with the
only overt sign of infection being circulating antiviral anti-
bodies. Acute infections involve fever, viremia, weight loss,
and leukopenia, and animals become severely anemic after
multiple episodes.
Ideally, to determine the molecular basis of virulence, one
would like to compare the structures of viral molecular
clones that differ in the severity of the disease they cause. To
date, however, there are no published reports of infectious
molecular clones of EIAV, much less pathogenic ones. The
objective is further complicated by the observation that most
virus stocks that are pathogenic for the horse cannot be
propagated readily in established tissue culture cell lines,
although they will replicate in primary horse leukocyte
cultures (14, 17). However, recent studies with HIV (8) have
suggested that it is wise to minimize or eliminate passage in
culture of a virulent virus stock, since selective pressures in
culture can be very different from those in the infected host.
It therefore appears advisable to derive molecular clones of
EIAV directly from infected equine tissue. Before this can
be accomplished, it is necessary to assess the quantity and
location of viral DNA in an acutely infected horse. That
assessment is the subject of this report.
* Corresponding author.
MATERIALS AND METHODS
Reagents. Equine dermal and kidney cell lines that pro-
duce EIAV were established after extended passaging of the
Wyoming strain in horse leukocyte cultures (18, 19). Virus
from fetal kidney cells were subsequently used to produc-
tively infect the canine thymus Cf2th cell line (1). Virus from
these cell lines is not pathogenic for the horse.
A replication-defective molecular clone of EIAV from
equine dermal cells has been completely sequenced (24, 25).
Its only known defects are a premature termination codon in
the pol gene and a single-base insertion in env.
Preparation of leukocytes (buffy coat) from peripheral
blood. To prepare leukocytes from an EIAV-infected horse,
we collected 50-ml samples of heparinized blood daily
through day 16, when the animal was killed. Blood samples
were allowed to stand at 4°C for 30 min, whereupon the
leukocyte-enriched portion above the erythrocyte layer was
removed. This plasma was centrifuged at about 500 x g for
15 min, yielding the buffy coat pellet and the supernatant
cell-free plasma. DNA was isolated from the cell pellets, and
the plasma was analyzed by immunoblotting (see below).
To determine the virus titer in the serum of the infected
horse at day 8 postinoculation (p.i.), we prepared leukocytes
as above and seeded them in T75 flasks containing 15 ml of
medium (RPMI 1640 containing 20% fetal bovine serum,
30% calf serum, and 1% sodium pyruvate) at 2 x 107 cells
per ml. Nonadherent cells were removed after 2 h, and virus
was applied in serial dilutions as described by Kobayashi
and Kono (15). The occurrence of a cytopathic effect within
about 12 days was the indicator of virus in the inoculum.
Supernatant fluid from cultures showing no cytopathic effect
was applied to a fresh culture. If no cytopathic effect was
observed in the second culture, fluid was passed to a third
culture. Only if this third culture showed no cytopathic effect
was the original inoculum scored as negative.
Immunoblotting. For the immunoblot shown in Fig. 1, 2 ml
of each plasma sample (see above) was diluted with phos-
phate-buffered saline, centrifuged at low speed to remove
any remaining cells and debris, and then centrifuged at
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FIG. 1. Appearance of virus following infection with EIAV. (A) Immunoblot of plasma samples. The horse was inoculated with EIAV
following collection of the day 0 blood sample. Each lane of the sodium dodecyl sulfate-10 to 20%o polyacrylamide gel contained the 100,000
x g pellet from 0.5 ml of plasma. The three additional lanes contained sucrose gradient-purified EIAV produced by equine fetal kidney cell
cultures (72-h harvest). Dilutions corresponding to the amount of virus derived from 0.01, 0.1, and 0.5 ml of tissue culture fluid were loaded
on the gel. The gel was electroblotted onto nitrocellulose, and the filter was incubated with antibody to EIAV p26 (10). Molecular masses (in
kilodaltons) of protein size standards are shown on the far right. (B) Detection by electron microscopy of EIAV particles in spleen at 16
days p.i.
100,000 x g for 90 min to pellet virus. Each pellet was taken
up in gel loading dye, and one-fourth of it (equivalent to all
the virus in 0.5 ml of plasma) was loaded onto a sodium
dodecyl sulfate-10 to 20% polyacrylamide gel. After electro-
phoresis, the gel was electroblotted onto nitrocellulose, and
the filter was subsequently incubated with a 1:1,000 dilution
of antiserum to purified EIAV p26 (10) and then with
251I-protein A at 3 x 105 cpm/ml. The filter was exposed to
X-ray film at -70°C for 18 h with an intensifying screen.
Preparation and analysis of DNA. DNA was prepared by
lysis of homogenized tissue or of buffy coat fractions in
buffer (0.05 M Tris [pH 7.5], 0.2 M sodium chloride, 0.1 M
EDTA) containing 0.1% sodium dodecyl sulfate and protein-
ase K at 100 jig/ml. After incubation at 37°C for several
hours, preparations were extracted with buffered phenol and
with a 24:1 mixture of chloroform and isoamyl alcohol and
banded in a cesium chloride (CsCl) density gradient in the
presence of ethidium bromide. The broad DNA band was
collected with a pipette, extracted with isopropanol (saturat-
ed with CsCI), and dialyzed. When it was examined on a 1%
agarose gel, there was no apparent difference among the
DNAs in their percentage of high-molecular-weight DNA.
Additional DNA from lymph nodes, spleen, and bone mar-
row was isolated essentially as above, but with ethanol
precipitation after phenol-chloroform extraction and without
CsCl banding. No differences in hybridization behavior were
observed between the two sets of DNA preparations. After
digestion with a restriction endonuclease, purified DNAs
were electrophoresed in a 1% agarose gel, transferred to
nitrocellulose, and probed with a nick-translated molecular
clone of EIAV (25). Hybridization was carried out at 42°C in
a solution containing 40% formamide, 6x SSC (lx SSC is
0.15 M NaCl plus 0.015 M sodium citrate) and nick-trans-
lated 32P-labeled probe at 4 x 106 cpm/ml. The specific
activity of the probe was about 108 cpm/,Lg. The most
stringent wash was with 0.5x SSC at 65°C. Relative band
intensities on the film were determined by densitometric
scanning.
Electron microscopy. Tissue which had been quick-frozen
and stored at -70°C was added to ice-cold 1.25% buffered
glutaraldehyde and allowed to stand overnight. Tissues were
embedded, sectioned, and examined by previously de-
scribed procedures (9).
RESULTS AND DISCUSSION
As virus stock we used serum from a horse infected with
the virulent Wyoming strain of EIAV. This stock, provided
by C. Issel, Louisiana State University, is known to cause
acute disease and early death. This serum (1 ml; 106 infec-
tious units/ml in horse leukocyte culture) was inoculated
intravenously into a 3-year-old Arabian quarter horse mare.
Blood samples were drawn daily, and tissue samples were
collected and quick-frozen at day 16 p.i. after the animal had
become moribund and was killed. The horse developed a
fever at 7 days p.i. and remained febrile (39.4 to 41.1°C) until
death. Necropsy demonstrated petechiation and ecchy-
moses of mucous membranes and serosa, and enlarged
hemorrhagic visceral lymph nodes, which are typical of
acute EIAV infection. Analysis of blood samples drawn
during the course of the infection showed declines in the
number of circulating lymphocytes and monocytes and a
sharp drop (about sixfold) in the number of circulating
platelets; these findings are also typical of EIAV infection (6,
20). As expected for acute infection with virulent EIAV, the
horse never became anemic. Antibody to EIAV p26 was first
detectable by the agar gel immunodiffusion assay (6) on day
16 p.i.
Appearance of virus in blood and tissue. Development of
viremia during EIAV infection has typically been monitored
p26- 40
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by tissue culture assay at various times after infection (15,
16, 23). Since the only cells susceptible to infection by field
strains are leukocytes and since multiple dilutions and time
points are often desired, this procedure can be very labori-
ous and time-consuming. We have therefore taken advan-
tage of the availability of high-titer monospecific antiserum
raised against the purified EIAV gag protein p26 (10) to
monitor the amount of virus in daily plasma samples by
immunoblotting (Fig. 1A). Low levels of virus were detect-
able as early as day 6 p.i., and the maximum level was
reached by day 9 p.i. and was maintained through day 16 p.i.
To estimate how much virus was present at days 9 through
16 p.i., we included (on the same blot) samples of the
avirulent Malmquist derivative (19) of the Wyoming strain of
EIAV, which is adapted to and produced by equine fetal
kidney cells in culture. We found that for equal volumes of
plasma or tissue culture medium, the intensity of the p26
band was about the same (compare days 9 through 16 with
EIAV at 0.5 ml). That is, during the acute stage of the
disease, horse plasma contains as much virus per unit
volume as tissue culture fluid from cells selected for high
EIAV productivity. Thus, the extreme virulence of this virus
(16 days from initial infection to death) is correlated with
massive viral replication, which is unusual for lentivirus
infections.
We also measured the infectivity of various dilutions of
day 8 p.i. serum samples on horse leukocyte cultures (15)
and established a titer of 104.8 horse leukocyte infectious
doses per ml for day 8 p.i. serum (data not shown). If the
approximately 10-fold increase in p26 from day 8 to day 9
seen in the immunoblot is indicative of a 10-fold increase in
titer over the same period, the day 9 titer would be about 106
horse leukocyte infectious doses per ml. This value would
agree well with previous estimates of EIAV titer in serum at
the peak of an acute episode (15, 16, 23).
Virus was also detectable in tissue. Frozen samples of
spleen (Fig. 1B) and splenic lymph node (day 16 p.i.) were
fixed and examined by electron microscopy. Although ultra-
structural preservation was poor owing to the freezing and
thawing, virus was nevertheless seen in both tissues. Other
tissues were not examined.
Levels of viral DNA in infected tissue. Having established
an acute EIAV infection exhibiting virus in both blood and
tissue, we tested for the presence of EIAV viral DNA. DNA
was prepared from various tissues collected when the animal
was killed on day 16 p.i. and from leukocyte preparations
(buffy coats) obtained from daily blood samples. Restriction
enzyme digests of equal amounts of these DNAs were
subjected to agarose gel electrophoresis, Southern transfer
onto nitrocellulose, and probing with a 32P-labeled molecular
clone of EIAV (25).
Hybridizing bands were consistently strongest in liver
DNA (Fig. 2A), but DNAs from the spleen, splenic lymph
nodes, renal lymph nodes, gastrohepatic lymph nodes, and
bone marrow (Fig. 3) were also strongly positive. DNAs
from the kidneys, choroid plexus, and buffy coat (days 14,
15, and 16 p.i.) contained less viral DNA, and brain DNA
was negative. Thus, at 16 days p.i., the highest concentra-
tion of EIAV viral DNA is found in the liver, spleen, lymph
nodes, and bone marrow.
To test whether leukocyte DNA contained more EIAV
sequences at an earlier time, we examined Southern trans-
fers of the daily samples (Fig. 2B). Hybridizing DNA was
first detected in the day 10 p.i. sample, but this and subse-
quent samples contained little EIAV DNA until days 15 and
16 p.i. Thus, at day 16 p.i., tissue DNA was strongly
positive, whereas the same amount of buffy coat DNA was
very weak at day 10 p.i. and became moderately positive by
day 16 p.i.
Given the difference in hybridization between tissue and
buffy coat DNA and the total size of, say, the liver and of the
buffy coat fraction, we can calculate the relative amounts of
EIAV DNA in tissue and in blood cells at day 16 p.i.
Relevant values include (i) a lOx densitometric difference in
intensity of the 5.2-kilobase (kb) band in liver and in day 16
buffy coat (Fig. 2A) (this varies somewhat from blot to blot,
but lOx is a reasonable middle value); (ii) a total of 2.3 mg of
DNA per g of liver; (iii) an estimated value of 7.4 kg for the
weight of the liver for a 500-kg horse; (iv) 5,500 leukocytes
per ,ul at day 16 (actual number); and (v) estimated value of
53 liters for the blood volume for a 500-kg horse. The result
is that on day 16 p.i. the vast majority of EIAV DNA is
located in the tissues. In the liver alone there is almost 90
times more EIAV DNA than in the total buffy coat fraction.
To estimate the absolute amount of viral DNA being
detected, we coelectrophoresed known amounts of an EIAV
molecular clone with 10-pg samples of tissue DNA (Fig. 2C).
Hybridization of the Southern transfer showed that infected
liver contained between 0.6 and 6 copies per cell of EIAV
DNA (Fig. 2C, compare lane 1 with lanes 14 and 15).
However, it is highly unlikely that all cells in the liver are
infected. Examination by immunofluorescence of livers from
EIAV-infected horses revealed that infected cells are located
predominantly within sinusoids and appear to be Kupffer
cells (21). Thus, if Kupffer cells constitute 10% of the total
cells in the liver (12) and if all of them were infected, each
contained on the average between 6 and 60 copies of EIAV
viral DNA. If less than 100% of the cells were infected or if
significant numbers of them had been destroyed by day 16
p.i., the per-cell levels of DNA in the surviving cells would
of course be higher.
EIAV DNA is mostly unintegrated. To determine whether
the observed viral DNA is integrated into cellular DNA or is
present as unintegrated molecules, we hybridized Southern
transfers of tissue DNA which had been digested with
restriction enzymes that produce diagnostic fragments. As a
reference we used the known restriction map of a
Malmquist-Wyoming EIAV molecular clone derived from
equine dermal cells (25). Given the heterogeneity found
among EIAV isolates (see reference 5 for a review), we
expected differences between the reference and the experi-
mental viral DNA for some enzymes, but we assumed that
there would be others that would produce comigrating and
hence interpretable fragments. This turned out to be the
case.
Digestion with an enzyme that cuts the genome only once
is a convenient way to distinguish integrated from uninte-
grated viral DNA, since only unintegrated genomes will
yield detectable fragments of predictable sizes. Digestion of
tissue DNA with each of three enzymes that cut the refer-
ence genome only once (SstI, NdeI, and PstI) yielded
fragments that must have originated from linear unintegrated
DNA (Fig. 3). For example, SstI cuts the reference genome
at base 3018 and therefore would produce fragments of 3.0
and 5.2 kb from a linear unintegrated provirus. Fragments of
this size were observed in SstI digests of all tissues exam-
ined, including the spleen, renal and splenic lymph nodes,
kidneys, and bone marrow. NdeI cuts the reference genome
at base 5725 and therefore would produce fragments of 5.7
and 2.5 kb from a linear unintegrated viral genome. These
fragments were observed in each of the three tissue DNAs
examined: spleen, renal lymph node, and bone marrow.
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FIG. 2. EIAV DNA in tissues of an infected horse. (A) Southern transfer of DNA from tissues at 16 days p.i. and from circulating
leukocytes at days 14, 15, and 16 p.i. Each lane contained about 5 ,ug ofDNA which had been digested with BamHI. The filter was exposed
to X-ray film for 3 days at -70°C with an intensifying screen. Abbreviations: SLN, splenic lymph nodes; RLN, renal lymph nodes; GHLN,
gastrohepatic lymph nodes; C.P., choroid plexus; B.C., d16, buffy coat, day 16 p.i. The sizes (in kilobases) ofDNA standards are shown on
the right. (B) DNA from daily buffy coat preparations. Each lane contained about 5 ,ug of a BamHI digest. The film was deliberately
overexposed to enable detection of bands in the samples taken on days 11 through 13. (C) Quantitation of EIAV proviral DNA in infected
tissue. Samples (10 ,ug) of the indicated tissue DNA were digested with BamHI and subjected to Southern transfer analysis. The filter was
exposed to X-ray film for 3 days at -70°C with an intensifying screen. Lanes 14 and 15 contain DNA from a molecular clone of EIAV (25)
in amounts equivalent to 0.6 and 6 copies per cell for 10 jLg of mammalian cellular DNA. Hybridizing fragments of this clone and of the tissue
samples arise as shown in the diagrams; -, viral genome; *---, cellular flanking DNA; A arms. Except where noted, tissue samples
are from an acutely infected horse 16 days p.i. Abbreviations: B.C., d 15, buffy coat at day 15; C.P., choroid plexus; spleen, d 10, spleen from
an acutely infected horse 10 days p.i.; spleen, Ab+, spleens from horses with circulating antibody to EIAV p26. The faint band at about 7 kb
in lane 12 was not reproducible.
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FIG. 3. Infected tissues contain unintegrated EIAV DNA. Tissue DNA (10 ,g) was digested with the indicated enzyme and subjected to
Southern transfer analysis. Cleavage sites in the reference genome are indicated below each hybridization panel. Lanes labeled + contain
DNA from an EIAV-producing (Malmquist-Wyoming strain) canine thymus cell line, whose cells contain predominantly unintegrated DNA.
Abbreviations: RLN, renal lymph nodes; BM, bone marrow; L, fragments derived only from linear unintegrated genomes; C, fragments
derived only from circular genomes; L,C,I, fragments derived from linear, circular, or integrated genomes.
PstI, which cuts the reference genome at base 4436, also
gave the expected fragments of 4.4 and 3.8 kb in digests of
spleen and renal lymph node DNA. The most probable
conclusion from these results is that the tissues contain
linear unintegrated viral DNA. This conclusion was con-
firmed by hybridizing a Southern transfer of undigested
spleen DNA; a strongly hybridizing band at the size ex-
pected for linear unintegrated genomes (8.2 kb) was ob-
served (Fig. 3).
The tissues also appear to contain circular unintegrated
viral DNA. This can be deduced from the existence of the
8.2-kb band in tissue DNA after digestion with each of the
above three enzymes. This band presumably results from the
single cleavage of a circular molecule, generating a linear
molecule of genome length. The 8.2-kb band could also
result from partial digestion of unintegrated linear DNA, but
we think this is unlikely since its intensity did not vary with
the ratio of enzyme to DNA, with the time of digestion, or
with the DNA preparation.
Digestion with XbaI, which cuts the reference genome
twice (at bases 1913 and 6142), confirmed the above conclu-
sions. A linear unintegrated molecule should generate frag-
ments of 1.9, 4.2, and 2.05 kb, all of which were observed in
DNA from the spleen, renal lymph nodes, and bone marrow.
A circular molecule containing two long terminal repeats
should generate, in addition to the 4.2-kb internal fragment,
a 3.95-kb fragment; this was observed in the renal lymph
node DNA but only weakly in the bone marrow and spleen
DNA. Integrated DNA should also yield the internal 4.2-kb
fragment. The face that the intensities of the 4.2-, 2.05-, and
1.9-kb bands are similar indicates that most (but presumably
not all) of the EIAV DNA in these cells is unintegrated.
Finally, the restriction digests show that the genome size
of the predominant virus(es} in the infected horse was
indistinguishable from that of the reference genome, which is
a replication-defective molecular clone derived from equine
tissue culture cells. This is significant because the sequence
of that defective clone (24, 25) contained neither a nefgene
(unlike HIV) nor a vip gene (unlike both HIV and visna
lentivirus), suggesting that an infectious EIAV genome
might well be significantly larger. The size similarity be-
tween the defective clone and the predominant forms in the
infected horse renders that possibility less likely.
Antibody-positive asymptomatic horses do not contain de-
tectable proviral DNA. Between episodes of acute disease,
EIAV is not detectable in either blood or tissue. We sur-
veyed DNAs from various tissues taken from six EIAV
antibody-positive but asymptomatic horses for the presence
of EIAV DNA. Tissues included the spleen, splenic and
renal lymph nodes, and kidneys. All Southern blot results
were negative, with a level of sensitivity of about 0.05 copy
per cell (Fig. 2C). Since blood and tissues from horses with
chronic disease are infectious, we assume that they contain
EIAV DNA. However, if the latent genomes are present in
low copy number in a very small percentage of cells, a much
more sensitive technique (e.g., the polymerase chain reac-
tion) will be required to reveal them.
Target cell. Part of the evidence for the hypothesis that
EIAV replication occurs predominantly in monocytes or
macrophages or both is the observation that field strains of
the virus can be propagated only in horse leukocyte cultures
(14, 17). We have extended previous studies by surveying 10
additional cell lines for susceptibility to infection by the
Wyoming strain. We applied 104 to 105 horse leukocyte
c
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infectious doses to 2 x 105 cells in the presence of DEAE-
dextran (20 ,ug/ml) and tested culture fluid for virus by
immunoblotting at 1, 4, and 12 weeks p.i. There was no
evidence of productive infection in any of the cell types
tested, including the Cf2th canine thymus line, the Fea feline
line, and several equine dermal cell lines and cell cultures
derived from fetal equine liver, skin, heart, spleen, and
ovaries. In contrast, horse leukocyte cultures were readily
infected. Viral replication in buffy coat preparations selected
for adherent cells was monitored by immunoblotting for
EIAV p26 and by the occurrence of a marked cytopathic
effect (data not shown).
These infectivity tests are thus completely consistent with
the results of the earlier work, in which viral replication was
observed only in horse leukocyte cultures. It is not known
how many of the different cell types found in a typical buffy
coat preparation can be infected with EIAV, but it can be
said with certainty that the adherent cells are susceptible (7,
14, 26, 27). These cells are almost exclusively mononuclear
(15) and hence presumably are of the monocyte-macrophage
lineage. Cells of this lineage have also been implicated as
targets for EIAV by immunofluorescence studies of acutely
infected tissue (21). Fluorescing cells were found in many
organs, including the spleen, liver, lymph nodes, kidney,
thymus, and bone marrow; by the criteria of morphology and
distribution, these cells appeared to be at least predomi-
nantly macrophages. On the grosser level of distribution of
viral DNA, the results presented here are consistent with a
monocyte-macrophage target. If we estimate the total num-
ber of macrophages per liver and the total number of
circulating monocytes, and if we assume that macrophages
and monocytes are equally susceptible to infection, we
should be able to predict the relative amount of EIAV DNA
in the liver versus buffy coat. The following assumptions are
made: (i) 10% of total liver cells are Kupffer cells (12); (ii)
cells make up 80% of the volume of the liver (2); (iii) the
volume of an average liver cell is about 3,300 ,um3; (iv) the
liver of a 500-kg horse weighs 7.4 kg; (v) the total blood
volume of a 500-kg horse is 53 liters; and (vi) on day 16 p.i.
there were 100 monocytes per ,ul of blood. The result is that
there are about 1.8 x 101l macrophages per liver and about
5.3 x 109 circulating monocytes, a 34-fold difference in favor
of the Kupffer cells. Given the uncertainties in the above
assumptions, this difference corresponds reasonably well to
the observed distribution of EIAV DNA on day 16 p.i.: there
was almost 90-fold more EIAV in the total liver than in the
total buffy coat. These results are therefore consistent with a
predominantly monocyte-macrophage target for EIAV.
In summary, we established an acute infection with a
virulent field strain of EIAV and determined the amounts
and distribution of viral DNA in blood and in various tissues.
We detected the highest concentrations of viral DNA in the
liver, lymph nodes, bone marrow, and spleen; however, the
kidney, choroid plexus, and buffy coat DNAs were also
positive. Brain DNA was negative (<0.05 genome per cell),
but since others have found viral antigen-containing cells in
the cerebrum and cerebellum (21), our negative result may
be due to insufficient sensitivity. We found that the great
majority of EIAV DNA is located in the tissues rather than
in peripheral blood and that most of it exists in an uninte-
grated state, both linear and circular. Assuming that the
macrophage is the principal target, each infected cell has
multiple copies of viral DNA. Strategies utilizing this infor-
mation are currently being employed to obtain molecular
clones of EIAV from various tissues and, where possible, at
various times after infection.
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